02.09.2020

WDA(H) 49276 Kingsley Specials Ltd - Multiple Products

Threat

The MHRA is currently investigating an incident where several medicines appear to have left the legal supply chain and have then been re-introduced via Kingsley Specials Ltd WDA(H) 49276, who purchased from a company that do not hold a wholesale dealers authorisation and then sold it on to a number of other wholesalers.

Find out more

Collapse the text

Source of the alert

MHRA

The risk concerns products
MDR Number


MDR 101-08/20

Company Name

WDA(H) 49276 Kingsley Specials Ltd

Recommendations for consumers
Brief description of the problem

The MHRA is currently investigating an incident where several medicines appear to have left the legal supply chain and have then been re-introduced via Kingsley Specials Ltd WDA(H) 49276, who purchased from a company that does not hold a wholesale dealers authorisation and then sold it on to a number of other wholesalers.

The products do appear to be genuine with legitimate batch numbers and safety features. These products are thought to have left the legitimate supply chain and been reintroduced between March and August 2020. This means that the correct transport and storage conditions cannot be guaranteed and, while unlikely, could impact their effectiveness.

Only the products mentioned in appendix 2 are within the scope of this alert. Please follow the advice below if you have received any of the products listed in appendix 2 from:

  • WDA(H) 42332 Smartway Pharmaceuticals Limited
  • WDA(H) 20912 Drugsrus Limited
  • WDA(H) 48028 Optimal Pharma Limited

Please note, the above wholesalers did not procure the products listed directly from Kingsley Specials Ltd. These products were sold onwards by intermediate companies and the companies listed above are not implicated of any wrongdoing and are co-operating with the MHRA to resolve the matter.

Advice for healthcare professionals

Please check your stocks of all the listed products for the relevant batches supplied from the above companies. If any relevant packs are identified, please quarantine and notify the Defective Medicines Report Centre (DMRC)/MHRA.

The above wholesalers have implemented safety measures by decommissioning the impacted packs, changing the status to STOLEN/INACTIVE in the National Medicines Verification System (NMVS). When scanning the serialised 2D code, the status of packs will report as ‘STOLEN’ and/or ‘INACTIVE.’ These products have been shared with other wholesalers prior to procurement at pharmacy level, th

Alert details

Country of origin

-

Country for notification

United Kingdom

Category

Pharmaceuticals

Source of the alert

MHRA - Medicines & Healthcare products Regulatory Agency, www.gov.uk/government/organisations/medicines-and-healthcare-products-regulatory-agency

Do you want to keep up with threats?

Download the application

Download our application and monitor threats! Scan products and feel safe every day. Check it out today!

Getwise Sp. z o.o.

Al. Ujazdowskie 22 lok 18
00-478 Warsaw, Poland

Copyright 2020 © Getwise Sp. z o.o. All rights reserved.